Ambit Biosciences Corp IPO Info

Company Name: Ambit Biosciences Corp
Stock Symbol: AMBI
Exchange: NASDAQ
Status: Priced
IPO Date: 5/16/2013
IPO Price: 8.00 (20.50%)
Underwriters
Citigroup, Leerink Swann, BMO Capital Markets, Baird

Amount of Offering: N/A
Number of Shares Offered: 8.125 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Ambit Biosciences is a biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases.

SEC Filings

News Headlines